CSLLY
Price
$86.16
Change
+$0.33 (+0.38%)
Updated
Jan 17 closing price
Capitalization
82.71B
THTX
Price
$1.72
Change
-$0.01 (-0.58%)
Updated
Jan 17 closing price
Capitalization
79.84M
Ad is loading...

CSLLY vs THTX

Header iconCSLLY vs THTX Comparison
Open Charts CSLLY vs THTXBanner chart's image
CSL
Price$86.16
Change+$0.33 (+0.38%)
Volume$75.27K
Capitalization82.71B
Theratechnologies
Price$1.72
Change-$0.01 (-0.58%)
Volume$84.06K
Capitalization79.84M
CSLLY vs THTX Comparison Chart
Loading...
CSLLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSLLY vs. THTX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSLLY is a Hold and THTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CSLLY: $86.16 vs. THTX: $1.72)
Brand notoriety: CSLLY and THTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSLLY: 90% vs. THTX: 69%
Market capitalization -- CSLLY: $82.71B vs. THTX: $79.84M
CSLLY [@Biotechnology] is valued at $82.71B. THTX’s [@Biotechnology] market capitalization is $79.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSLLY’s FA Score shows that 1 FA rating(s) are green whileTHTX’s FA Score has 1 green FA rating(s).

  • CSLLY’s FA Score: 1 green, 4 red.
  • THTX’s FA Score: 1 green, 4 red.
According to our system of comparison, THTX is a better buy in the long-term than CSLLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSLLY’s TA Score shows that 4 TA indicator(s) are bullish while THTX’s TA Score has 3 bullish TA indicator(s).

  • CSLLY’s TA Score: 4 bullish, 3 bearish.
  • THTX’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, CSLLY is a better buy in the short-term than THTX.

Price Growth

CSLLY (@Biotechnology) experienced а -1.11% price change this week, while THTX (@Biotechnology) price change was -8.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

THTX is expected to report earnings on Oct 11, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSLLY($82.7B) has a higher market cap than THTX($79.8M). CSLLY YTD gains are higher at: -1.599 vs. THTX (-4.972). CSLLY has higher annual earnings (EBITDA): 4.73B vs. THTX (11.6M). CSLLY has more cash in the bank: 885M vs. THTX (38.9M). THTX has less debt than CSLLY: THTX (57.8M) vs CSLLY (12.2B). CSLLY has higher revenues than THTX: CSLLY (14.7B) vs THTX (84.3M).
CSLLYTHTXCSLLY / THTX
Capitalization82.7B79.8M103,634%
EBITDA4.73B11.6M40,802%
Gain YTD-1.599-4.97232%
P/E Ratio31.62N/A-
Revenue14.7B84.3M17,438%
Total Cash885M38.9M2,275%
Total Debt12.2B57.8M21,107%
FUNDAMENTALS RATINGS
CSLLY vs THTX: Fundamental Ratings
CSLLY
THTX
OUTLOOK RATING
1..100
5024
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
7643
P/E GROWTH RATING
1..100
721
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSLLY's Valuation (2) in the null industry is significantly better than the same rating for THTX (100). This means that CSLLY’s stock grew significantly faster than THTX’s over the last 12 months.

CSLLY's Profit vs Risk Rating (100) in the null industry is in the same range as THTX (100). This means that CSLLY’s stock grew similarly to THTX’s over the last 12 months.

CSLLY's SMR Rating (98) in the null industry is in the same range as THTX (100). This means that CSLLY’s stock grew similarly to THTX’s over the last 12 months.

THTX's Price Growth Rating (43) in the null industry is somewhat better than the same rating for CSLLY (76). This means that THTX’s stock grew somewhat faster than CSLLY’s over the last 12 months.

THTX's P/E Growth Rating (1) in the null industry is significantly better than the same rating for CSLLY (72). This means that THTX’s stock grew significantly faster than CSLLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSLLYTHTX
RSI
ODDS (%)
Bullish Trend 11 days ago
82%
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
46%
N/A
Momentum
ODDS (%)
Bullish Trend 11 days ago
55%
N/A
MACD
ODDS (%)
Bullish Trend 11 days ago
67%
N/A
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
51%
Bullish Trend 11 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
59%
Bullish Trend 11 days ago
75%
Advances
ODDS (%)
Bullish Trend 11 days ago
54%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 17 days ago
63%
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
Bearish Trend 11 days ago
56%
Bullish Trend 11 days ago
77%
View a ticker or compare two or three
Ad is loading...
CSLLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDXC5.940.29
+5.13%
ChromaDex Corp
AGIO32.420.60
+1.89%
Agios Pharmaceuticals
PEP148.251.71
+1.17%
PepsiCo
WF32.13-0.02
-0.06%
Woori Financial Group
ANIX2.41-0.17
-6.59%
Anixa Biosciences

CSLLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSLLY has been loosely correlated with ADPT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CSLLY jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSLLY
1D Price
Change %
CSLLY100%
+0.38%
ADPT - CSLLY
34%
Loosely correlated
-1.59%
RXRX - CSLLY
34%
Loosely correlated
+2.03%
VIR - CSLLY
33%
Poorly correlated
+0.60%
FOLD - CSLLY
33%
Poorly correlated
+0.53%
CDXS - CSLLY
33%
Poorly correlated
+1.63%
More

THTX and

Correlation & Price change

A.I.dvisor tells us that THTX and IDYA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that THTX and IDYA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THTX
1D Price
Change %
THTX100%
-0.58%
IDYA - THTX
27%
Poorly correlated
-2.38%
GNPX - THTX
27%
Poorly correlated
+2.86%
CSLLY - THTX
26%
Poorly correlated
+0.38%
CDXS - THTX
26%
Poorly correlated
+1.63%
BEAM - THTX
25%
Poorly correlated
+0.17%
More